| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL NDC 70121-1732-09 | 24 Pouch | Amneal Pharmaceuticals LLC | 70121-1732-09 | Amneal Pharmaceuticals LLC | Current shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 200 mL NDC 70121-1733-09 | 24 Pouch | Amneal Pharmaceuticals LLC | 70121-1733-09 | Amneal Pharmaceuticals LLC | Current shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 100 mL NDC 70121-1734-03 | 12 Pouch | Amneal Pharmaceuticals LLC | 70121-1734-03 | Amneal Pharmaceuticals LLC | Current shortage context |
| Ropivacaine Hydrochloride 7.5 mg / mL Injection 20 mL NDC 55150-0199-20 | 25 Vial, Single-Dose | Eugia US LLC | 55150-0199-20 | Eugia US LLC | Current shortage context |
| Ropivacaine Hydrochloride 10 mg / mL Injection 10 mL NDC 55150-0200-10 | 25 Vial, Single-Dose | Eugia US LLC | 55150-0200-10 | Eugia US LLC | Current shortage context |
| ropivacaine hydrochloride 2 mg / mL Injection 20 mL NDC 43066-0015-10 | 10 Vial | Baxter Healthcare Corporation | 43066-0015-10 | Baxter Healthcare Corporation | Historical shortage context |
| ropivacaine hydrochloride 5 mg / mL Injection 20 mL NDC 43066-0019-10 | 10 Vial | Baxter Healthcare Corporation | 43066-0019-10 | Baxter Healthcare Corporation | Historical shortage context |
| ropivacaine hydrochloride 5 mg / mL Injection 30 mL NDC 43066-0023-10 | 10 Vial | Baxter Healthcare Corporation | 43066-0023-10 | Baxter Healthcare Corporation | Historical shortage context |
| ropivacaine hydrochloride 10 mg / mL Injection 20 mL NDC 43066-0027-10 | 10 Vial | Baxter Healthcare Corporation | 43066-0027-10 | Baxter Healthcare Corporation | Historical shortage context |
| ropivacaine hydrochloride 2 mg / mL Injection 100 mL NDC 25021-0671-82 | 10 Bag | Sagent Pharmaceuticals | 25021-0671-82 | Sagent Pharmaceuticals | Historical shortage context |
| ropivacaine hydrochloride 2 mg / mL Injection 200 mL NDC 25021-0671-87 | 10 Bag | Sagent Pharmaceuticals | 25021-0671-87 | Sagent Pharmaceuticals | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL NDC 55150-0196-99 | 1 Bottle, Glass | Eugia US LLC | 55150-0196-99 | Eugia US LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 20 mL NDC 55150-0197-20 | 25 Vial, Single-Dose | Eugia US LLC | 55150-0197-20 | Eugia US LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 10 mL (Naropin) NDC 63323-0285-10 | 5 Ampule | Fresenius Kabi USA, LLC | 63323-0285-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 10 mL (Naropin) NDC 63323-0285-13 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0285-13 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 20 mL (Naropin) NDC 63323-0285-20 | 5 Ampule | Fresenius Kabi USA, LLC | 63323-0285-20 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 20 mL (Naropin) NDC 63323-0285-23 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0285-23 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL (Naropin) NDC 63323-0285-61 | 24 Bag | Fresenius Kabi USA, LLC | 63323-0285-61 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 200 mL (Naropin) NDC 63323-0285-63 | 24 Bag | Fresenius Kabi USA, LLC | 63323-0285-63 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 200 mL (Naropin) NDC 63323-0285-64 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0285-64 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL (Naropin) NDC 63323-0285-65 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0285-65 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL (Naropin) NDC 63323-0285-67 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0285-67 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 100 mL (Naropin) NDC 63323-0285-68 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0285-68 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 200 mL (Naropin) NDC 63323-0285-73 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0285-73 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 100 mL (Naropin) NDC 63323-0286-00 | 12 Bottle | Fresenius Kabi USA, LLC | 63323-0286-00 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 20 mL (Naropin) NDC 63323-0286-20 | 5 Ampule | Fresenius Kabi USA, LLC | 63323-0286-20 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 20 mL (Naropin) NDC 63323-0286-23 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-23 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL (Naropin) NDC 63323-0286-30 | 1 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-30 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL (Naropin) NDC 63323-0286-31 | 5 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-31 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL (Naropin) NDC 63323-0286-35 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-35 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL (Naropin) NDC 63323-0286-38 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-38 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL (Naropin) NDC 63323-0286-95 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0286-95 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 7.5 mg / mL Injection 20 mL (Naropin) NDC 63323-0287-20 | 5 Ampule | Fresenius Kabi USA, LLC | 63323-0287-20 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 7.5 mg / mL Injection 20 mL (Naropin) NDC 63323-0287-21 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0287-21 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 10 mg / mL Injection 10 mL (Naropin) NDC 63323-0288-10 | 5 Ampule | Fresenius Kabi USA, LLC | 63323-0288-10 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 10 mg / mL Injection 20 mL (Naropin) NDC 63323-0288-21 | 25 Vial, Single-Dose | Fresenius Kabi USA, LLC | 63323-0288-21 | Fresenius Kabi USA, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 10 mL NDC 70069-0061-10 | 10 Vial | Somerset Therapeutics, LLC | 70069-0061-10 | Somerset Therapeutics, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 10 mL NDC 70069-0061-25 | 25 Vial | Somerset Therapeutics, LLC | 70069-0061-25 | Somerset Therapeutics, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 2 mg / mL Injection 20 mL NDC 70069-0062-10 | 10 Vial | Somerset Therapeutics, LLC | 70069-0062-10 | Somerset Therapeutics, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL NDC 70069-0064-01 | 1 Vial | Somerset Therapeutics, LLC | 70069-0064-01 | Somerset Therapeutics, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL NDC 70069-0064-10 | 10 Vial | Somerset Therapeutics, LLC | 70069-0064-10 | Somerset Therapeutics, LLC | Historical shortage context |
| Ropivacaine Hydrochloride 5 mg / mL Injection 30 mL NDC 70069-0064-25 | 25 Vial | Somerset Therapeutics, LLC | 70069-0064-25 | Somerset Therapeutics, LLC | Historical shortage context |